These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation. Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530 [TBL] [Abstract][Full Text] [Related]
5. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L. Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737 [TBL] [Abstract][Full Text] [Related]
6. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation. Schiffer CA Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734 [No Abstract] [Full Text] [Related]
7. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies. Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995 [TBL] [Abstract][Full Text] [Related]
8. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944 [TBL] [Abstract][Full Text] [Related]
9. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation. Estcourt LJ; Stanworth SJ; Murphy MF JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031 [TBL] [Abstract][Full Text] [Related]
10. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit. Vamvakas EC; Hitzler WE Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342 [TBL] [Abstract][Full Text] [Related]
11. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients. Diedrich B; Ringdén O; Watz E; Shanwell A Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669 [TBL] [Abstract][Full Text] [Related]
12. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342 [TBL] [Abstract][Full Text] [Related]